-
Mashup Score: 7
Stanford has ranked among the top 10 cancer hospitals in the nation
Source: med.stanford.eduCategories: General Medicine NewsTweet
-
Mashup Score: 1Stanford School of Medicine (@stanford.med) • Instagram reel - 16 day(s) ago
112 likes, 2 comments – stanford.med on July 24, 2025: “A visionary $100 million matching grant from the Weill Family Foundation is bringing together two leading cancer centers to launch the Weill Cancer Hub West — an innovative collaboration among some of the nation’s most talented scientists that will transform cancer research and care in the next decade. The initiative will harness the expertise and resources of two world-class institutions — the Stanford Cancer Institute and the UCSF Helen Diller Family Comprehensive Cancer Center — to lead cross-specialty collaborations that accelerate new discoveries and speed the development of innovative new treatments for patients. “Good things happen when people collaborate,” Sandy Weill said. “University of California, San Francisco and Stanford have long been engines of innovation and biotechnology, and today they are poised to shape the future. With the combined power of the brightest scientific minds and AI capabilities, the Weill Cancer
Source: www.instagram.comCategories: General Medicine NewsTweet-
See this Instagram video by @stanford.med https://t.co/v7jPtsbVH4
-
-
Mashup Score: 0Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis - 6 month(s) ago
npj Digital Medicine – Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
In a systematic review and meta-analysis SCI member Eleni Linos & team found that clinicians benefit from #AI assistance in #SkinCancer diagnosis regardless of their experience level. https://t.co/u0kvPiWO55 @linos_eleni https://t.co/82c1PXUn23
-
-
Mashup Score: 3Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era - 6 month(s) ago
This cohort study examines if rates of overtreatment of men with prostate cancer with limited life expectancy have persisted in the active surveillance era and whether overtreatment varies by tumor risk or treatment type.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
SCI member @johnleppert & others found that overtreatment of low-risk #ProstateCancer with surgery or radiotherapy < while overtreatment of men with limited life expectancy and intermediate- or high-risk disease >, mainly with radiotherapy. https://t.co/ROffY1mF2s
-
-
Mashup Score: 5
350Background: Esophageal (EAC), gastroesophageal junction (GEJ) or gastric (GAC) adenocarcinoma share similar etiologies and treatment approaches. However, it is not clear if they possess similar or different prognostic and biological characteristics. We …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
SCI members @LabDfelsher, George Fisher & others found that 3 gastrointestinal #adenocarcinomas possess substantially different OS that appears differentially associated with HER2 status, mutp53, mutKRAS and MYC amplification. https://t.co/YCBcqWHIFU #GI25
-
-
Mashup Score: 2The intestinal microbiota and cellular therapy: implications for impact and mechanisms - 6 month(s) ago
Xie and Smith review the current understanding of the role of the microbiota and its diversity on responses to cellular therapies, including stem cell tran
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
The microbiota modulates immune responses and influences cellular cancer therapies like hematopoietic cell transplantation and CAR T-cell therapy. SCI member @MelodySmithMD explores the mechanisms behind these interactions and future research directions. https://t.co/nmVrgFfYF4
-
-
Mashup Score: 0
Abstract. Purpose: A first-in-human phase one study was conducted in nasopharyngeal carcinoma (NPC) patients to assess the safety and tolerability of VK-2019, a small molecule selective inhibitor of Epstein-Barr virus Nuclear Antigen 1 (EBNA1). Patients and Methods: Pharmacokinetic and pharmacodynamic studies, including circulating tumor EBV DNA plasma levels, were performed. Twenty-three patients received VK-2019 orally once daily at doses ranging from 60 to 1800 mg using an accelerated titration design, with cohort expansion at 1800 mg. EBV genome copy number and spatial transcriptomic analyses were conducted on biopsies collected from three patients at baseline and after treatment. Results: VK-2019 was well tolerated. One patient achieved a partial response. Pharmacokinetic results demonstrated good systemic exposure, with high intersubject variability. Decreases in circulating tumor EBV DNA plasma levels were observed in some patients. VK-2019 reduced EBV genome copy number and vir
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet-
SCI member Dimitrios Colevas & others found VK-2019 demonstrated an acceptable safety profile, achieved micromolar plasma concentrations, and showed on-target biological activity in tumors from patients with advanced EBV-positive #NasopharyngealCarcinoma. https://t.co/qmDsXHwoEc https://t.co/G5SnRSZTPG
-
-
Mashup Score: 1Surgery and Suicide Deaths Among Patients With Cancer - 7 month(s) ago
This cohort study describes suicide incidence among patients with cancer compared with the general population and by surgical status and cancer treatment.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Stanford researchers found higher suicide deaths among cancer patients who did not undergo surgery. @AllisonKurian @linos_eleni https://t.co/kd2MFxXS7q
-
-
Mashup Score: 23Complex rearrangements fuel ER+ and HER2+ breast tumours - 7 month(s) ago
Nature – A study identifies three dominant genomic archetypes of breast cancer induced by discrete mutational processes, describing a continuum of genomic profiles and detailing the mechanisms…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
SCI member @cncurtis & others found #BreastCancer spans three genomic archetypes: ER+ high-risk tumors with complex amplifications (ecDNA), HRD-like TNBC, and stable ER+ typical-risk tumors. These suggest new treatment targets, like PARP inhibitors. https://t.co/GlKzAoFnco https://t.co/DnLmgv0fiP
-
-
Mashup Score: 9
Nature Biomedical Engineering – ChatGPT can be leveraged to generate informative embeddings of genes and single cells.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
SCI member James Zou and postdoc Yiqun Chen explore how to create #ChatGPT embeddings of genes and #singlecell data to improve gene function prediction and cell annotation/analysis. https://t.co/vF6uZIZFbC @james_y_zou https://t.co/PxgEujuE3I
-
I am proud to share that U.S. News & World Report has ranked @StanfordHealth among the top ten #CancerHospitals in the nation. This ranking reflects our team's commitment to excellence across research, clinical innovation, and #PatientCare. https://t.co/kq2wJ8cIGM @usnews